These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
14. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537 [TBL] [Abstract][Full Text] [Related]
15. From thrombolytic megatrials to clinical policy-making: facing the facts. Naylor CD; Armstrong PW Can J Cardiol; 1995 Jun; 11(6):472-6. PubMed ID: 7780867 [No Abstract] [Full Text] [Related]
16. [Thrombolytic treatment of acute myocardial infarct. 1]. Soares-Costa JT; Soares-Costa TJ; Gabriel HM Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy. Molnar C; Buratti T; Wiedermann CJ; Tilg H Eur Cytokine Netw; 2000 Mar; 11(1):87-90. PubMed ID: 10705304 [TBL] [Abstract][Full Text] [Related]
18. Biochemical pharmacology and therapeutic aspects of thrombolytic agents. Fears R Pharmacol Rev; 1990 Sep; 42(3):201-22. PubMed ID: 2120714 [No Abstract] [Full Text] [Related]
19. [Experience with the thrombolytic therapy of myocardial infarct]. Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835 [No Abstract] [Full Text] [Related]
20. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study]. Franzosi MG Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828 [No Abstract] [Full Text] [Related] [Next] [New Search]